- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Slideshow
Some psoriasis studies you shouldn't miss
Author(s):
In this slideshow, we highlight some of this year's clinical advances in psoriasis and plaque psoriasis.
In this slideshow, we highlight some of this year's clinical advances in psoriasis and plaque psoriasis.
SKIN CANCER CHECKS IN PSORIASIS: As dermatologists become increasingly aware of comorbidities associated with psoriasis, questions of associated malignancy risk remain. Dr. Megan Noe emphasizes the need for skin cancer checks. (©SweetheartStudio/Shutterstock.com)
(©SweetheartStudio/Shutterstock.com)
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
The Value of Roflumilast Cream for Plaque Psoriasis
Deucravacitinib Approved by FDA for Treatment of Psoriasis
Plaque Psoriasis Management: Future Directions in Care
Biologic Therapy in Plaque Psoriasis: Treating During the COVID-19 Pandemic
Unmet Needs in Moderate to Severe Plaque Psoriasis Management
Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy
Plaque Psoriasis Patient Case 2: Switching Therapy at Treatment Failure
Factors in Selecting Biologic Therapy for Moderate to Severe Plaque Psoriasis
Plaque Psoriasis: Biologic Therapy Toxicity Profiles
Bimekizumab’s Potential in Moderate-to-Severe Plaque Psoriasis
Related Content
